The Medicines Company has filed lawsuits against Teva Parenteral Medicines, Inc., Pliva Hrvatska d.o.o. and related entities in the United States District Court for the District of Delaware alleging patent infringement based on ANDA seeking USFDA approval to market and sell generic versions of The Medicines Company's Angiomax(R) product prior to expiration of U.S. Patent No. 7,598,343 ("the '343 patent"). Each lawsuit alleges infringement of the '343 patent which was issued on October 6, 2009. As per an earlier announcement, The Medicines Company has patent infringement lawsuits pending against the same parties in the United States District Court for the District of Delaware for infringement of its U.S. Patent No. 7,502,727.
No comments:
Post a Comment